Topical corticosteroid as a treatment for vitiligo

Case report

https://doi.org/10.53730/ijhs.v6nS9.12311

Authors

  • Gusti Ayu Dea Dwi Apriza Dharmayani Dermatology and Venereology Department in Wangaya Regional General Hospital, Denpasar, Bali, Indonesia
  • Tjokorda Dalem Pemayun Dermatology and Venereology Department in Wangaya Regional General Hospital, Denpasar, Bali, Indonesia

Keywords:

vitiligo, topical corticosteroid, skin, disease

Abstract

Introduction: Vitiligo is an acquired pigmentation disorder of the skin with the manifestation of white macules due to the release of melanocytes. All therapies for vitiligo are limited and no treatment is known to consistently produce re-pigmentation in all patients. Case Presentation: A 43-year-old woman with this disease came with the chief complaint of white patches on the right forearm and back of the right and left hands. The white patches do not itch but make the patient feel uncomfortable and lower her self-confidence. Conclusion: Patients with vitiligo are characterized by white patches that develop and expand slowly over time, but each person is different. Topical corticosteroids still remain the gold standard in the treatment of small localized areas.

Downloads

Download data is not yet available.

References

Allam, M & Riad, H. Concise Review of Recent Studies in Vitiligo. Qatar Medical Journal. 2013; p. 1-19.

Bergqvist, C and Ezzedine, K. Vitiligo: A Review. Dermatology. 2020; p. 571-592.

Bilal, A & Anwar, I. Guidelines for The Management of Vitiligo. Journal of Pakistan Association of Dermatologist. 2014; 24(1): 68-78.

Bleul, R & Eberlein, B. Therapeutic Management of Vitiligo. Journal of The German Society of Dermatology. 2018; p. 1309-1313.

Ghafourian E, et al. Vitiligo: Symptoms, Pathogenesis and Treatment. International Journal of Immunopathology and Pharmacology. 2014; 27(4): 485-489.

Kamaluddin. (2021). Government and Private Collaboration in Coping with Covid-19 in Sorong City. International Research Journal of Management, IT and Social Sciences, 8(5), 333-341. https://doi.org/10.21744/irjmis.v8n5.1907

Lopez, K et al. Update and New Medical Treatments for Vitiligo Review. Experimental and Therapeutic Medicine. 2021; 22: 1-11.

Passeron, T. Medical and Maintenance Treatments for Vitiligo. Dermatologic Clinics. 2017; 35(2): 163-170.

Peters, T & Yoo, K. What is Vitiligo?. The Society for Pediatric Dermatology. 2015; p. 1-2.

Phiske, M. Vitiligo in Children: A Birds Eye View. Current Pediatric Reviews. 2016; 12(1): 55-66.

Rahman, R & Hasija, Y. Exploring Vitiligo Susceptibility and Management: A Brief Review. Biomedical Dermatology. 2018; p. 1-13.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938

Wirawan, I. G. B. (2018). Surya Namaskara benefits for physical health. International Journal of Social Sciences and Humanities, 2(1), 43–55. https://doi.org/10.29332/ijssh.v2n1.78

Published

30-08-2022

How to Cite

Dharmayani, G. A. D. D. A., & Pemayun, T. D. (2022). Topical corticosteroid as a treatment for vitiligo: Case report. International Journal of Health Sciences, 6(S9), 877–882. https://doi.org/10.53730/ijhs.v6nS9.12311

Issue

Section

Peer Review Articles